{"organizations": [], "uuid": "26f797a335f639778e5c796f0874cd0fe0e1a1a7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180430.html", "section_title": "Archive News &amp; Video for Monday, 30 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-karo-pharma-determines-terms-for-r/brief-karo-pharma-determines-terms-for-rights-issue-idUSFWN1S713M", "country": "US", "domain_rank": 408, "title": "BRIEF-Karo Pharma Determines Terms For Rights Issue", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.034, "site_type": "news", "published": "2018-04-30T22:35:00.000+03:00", "replies_count": 0, "uuid": "26f797a335f639778e5c796f0874cd0fe0e1a1a7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-karo-pharma-determines-terms-for-r/brief-karo-pharma-determines-terms-for-rights-issue-idUSFWN1S713M", "ord_in_thread": 0, "title": "BRIEF-Karo Pharma Determines Terms For Rights Issue", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "karo pharma", "sentiment": "negative"}, {"name": "reuters) - karo pharma ab", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 30 (Reuters) - Karo Pharma AB:\n* THE TERMS FOR KARO PHARMAâ€™S RIGHTS ISSUE HAVE BEEN DETERMINED\n* FOR EACH EXISTING SHARE HELD AT RECORD DATE, SHAREHOLDERS WILL RECEIVE ONE (1) SUBSCRIPTION RIGHT\n* SUBSCRIPTION PRICE HAS BEEN SET AT SEK 24.00 PER SHARE * RIGHTS ISSUE WILL AT MOST RAISE SEK 1,314.7 MILLION BEFORE ISSUE COSTS\n* ISSUANCE OF A MAXIMUM OF 54,777,594 NEW ORDINARY SHARES * TWO (2) SUBSCRIPTION RIGHTS ENTITLING HOLDER TO SUBSCRIBE FOR ONE (1) ORDINARY NEW SHARE (I.E. A SUBSCRIPTION RATIO OF 1:2)\n* SUBSCRIPTION PERIOD WILL RUN BETWEEN 14 MAY 2018 UNTIL 29 MAY 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-30T22:35:00.000+03:00", "crawled": "2018-05-01T20:18:08.001+03:00", "highlightTitle": ""}